Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,220,787
-$8,959,804 QoQ
Shares Held
392,719
+24.9% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#129
of 1,408 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $31,020,308 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (91.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
392,719 | $28,220,787 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,044 | $565,670 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,749 | $463,316 | |
| 4 | TRLV |
Trulieve Cannabis Corp.
|
38,555 | $378,995 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,464 | $320,640 | |
| 6 | ALKS |
Alkermes plc.
|
5,489 | $287,623 | |
| 7 | VTRS |
Viatris Inc
|
17,301 | $274,739 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
14,674 | $235,224 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,220,787 | 392,719 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $37,180,591 | 314,530 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $35,364,730 | 281,074 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $42,478,440 | 272,385 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,663,778 | 259,118 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,260,003 | 247,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $47,399,578 | 242,602 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $39,961,560 | 230,512 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $36,349,861 | 214,821 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $40,435,191 | 204,870 | Shares | Sole | 2024-02-28 | |
| 2023-09-30 | $34,601,142 | 198,880 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $184,609 | 1,072 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $432,226 | 28,719 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $25,461,597 | 173,740 | Shares | Sole | 2023-06-12 | |
| 2022-09-30 | $24,057,531 | 162,233 | Shares | Sole | 2022-12-02 | |
| 2022-06-30 | $26,731,989 | 155,518 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $28,036,543 | 148,664 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $34,582,711 | 141,715 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $27,092,042 | 139,549 | Shares | Sole | 2021-11-23 | |
| 2021-06-30 | $24,922,295 | 133,732 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $19,462,323 | 123,586 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $18,100,238 | 109,367 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $17,040,386 | 103,044 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $13,705,233 | 100,009 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $546,787 | 4,646 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||